您的位置: 首页 > 农业专利 > 详情页

PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM
专利权人:
Jenny Agnes Greig;Anna P. Tretiakova;James M. Wilson
发明人:
James M. Wilson,Anna P. Tretiakova,Jenny Agnes Greig
申请号:
US13247306
公开号:
US20120058102A1
申请日:
2011.09.28
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention relates to gene therapy systems designed for the delivery of a therapeutic product to a subject using replication-defective virus composition(s) engineered with a built-in safety mechanism for ablating the therapeutic gene product, either permanently or temporarily, in response to a pharmacological agent—preferably an oral formulation, e.g., a pill. The invention is based, in part, on the applicants' development of an integrated approach, referred to herein as “PITA” (Pharmacologically Induced Transgene Ablation), for ablating a transgene or negatively regulating transgene expression. In this approach, replication-deficient viruses are used to deliver a transgene encoding a therapeutic product (an RNA or a protein) so that it is expressed in the subject, but can be reversibly or irreversibly turned off by administering the pharmacological agent; e.g., by administration of a small molecule that induces expression of an ablator specific for the transgene or its RNA transcript.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充